Literature DB >> 3521185

Clozapine in the treatment of tremor.

H Pakkenberg, B Pakkenberg.   

Abstract

In an open trial 25 tremor patients were treated with clozapine in small doses (18-75 mg per day). The effect was measured with a new movement analyzer. Nine of 12 essential tremor patients were greatly improved. In six of nine patients with Parkinson tremor and in two combined essential tremor/Parkinson tremor patients tremor almost disappeared. Sedation is a major side effect, but decreases in most patients with time. The risk of agranulocytosis makes blood control necessary.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521185     DOI: 10.1111/j.1600-0404.1986.tb03279.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  20 in total

1.  The tangled biology of tau.

Authors:  K C Wilhelmsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats.

Authors:  A Betz; K Ishiwari; A Wisniecki; N Huyn; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

3.  A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.

Authors:  Kimberly E Vanover; Adrienne J Betz; Suzanne M Weber; Francesco Bibbiani; Aiste Kielaite; David M Weiner; Robert E Davis; Thomas N Chase; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

Review 4.  Management of Parkinson's disease dementia : practical considerations.

Authors:  Arvid Rongve; Dag Aarsland
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 5.  Management of essential tremor.

Authors:  Theresa A Zesiewicz; Elmyra Encarnacion; Robert A Hauser
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 6.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  Overview of essential tremor.

Authors:  Theresa A Zesiewicz; Abinaya Chari; Israt Jahan; Amber M Miller; Kelly L Sullivan
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 8.  Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.

Authors:  Shyam C Panchal; William G Ondo
Journal:  Curr Psychiatry Rep       Date:  2018-01-27       Impact factor: 5.285

Review 9.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849

Review 10.  Clozapine: neuroleptic-induced EPS and tardive dyskinesia.

Authors:  D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.